CHICAGO, Jan. 3 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation, today announced that it will present and participate in a panel discussion during a special session of the of 26th Annual JPMorgan Healthcare Conference on January 9, 2008.
The Company's presentation will be delivered during a special
Biodefense Session hosted by JPMorgan and McKenna Long & Aldridge at 5:00
pm Pacific Time in the St. Francis Suite on the 12th floor of the Westin
St. Francis hotel in San Francisco, CA. The presentation will focus on the
Company's pre-NDA antibiotic, cethromycin, and its application as a
biodefense countermeasure. The panel will discuss public health
The program includes co-keynote addresses by:
-- Dr. Rajeev Venkeyya, Special Assistant to the President and Senior
Director for Biodefense at the White House Homeland Security Council
-- Brian Kamoie, Deputy Assistant Secretary Director, Office of Policy,
Strategic Planning & Communications Office of the Assistant Secretary
for Preparedness and Response U.S. Department of Health & Human
Following the Company's presentation and participation on the biodefense panel, there will be a question and answer session led by the moderator with audience participation.
About Advanced Life Sciences
Advanced Life Sciences is a biopharmaceutica
|SOURCE Advanced Life Sciences Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved